INFORMATION
SEARCH SITE


 

 

 


Surgical NaProTECHNOLOGY:
Surgery of the Heart 
 

About 30 years ago, the American Board of Obstetrics and Gynecology approved three new subspecialties in the field of obstetrics and gynecology.  These subspecialties were gynecologic oncology (women’s cancer), perinatology (high-risk pregnancies), and reproductive endocrinology (infertility and other reproductive hormones).  It was the hope when these subspecialties were developed that they would advance those three areas of women’s health.

As one looks back on the development of the reproductive endocrinology training programs, they originally started with the emphasis on pelvic surgery.  However, in 1978, when the first baby was born by in vitro fertilization (IVF), the specialty changed dramatically.  Its focus, over the last 12 years, has been on the development of the skills needed for IVF.  As a result, many younger reproductive endocrinologists do not, at this time, have the surgical skills necessary to do some basic and most advanced reconstructive pelvic surgeries.

Over a decade ago, the Society of Reproductive Surgeons, a group within the American Society of Reproductive Medicine, began to recognize this deficiency and foster the development of postgraduate fellowship programs which would have, as one of their major emphases, training in pelvic surgery, microsurgery, laser surgical applications, and so forth.  These training programs have grown slowly over the past 10 years, but it is in this area that Surgical NaProTECHNOLOGY has its major focus.

Surgical NaProTECHNOLOGY is a specialized form of gynecologic surgery whose primary aim is to reconstruct the uterus, fallopian tubes and ovaries in such a way that pelvic adhesive disease can be eliminated and not caused by the surgical procedure itself.  It is, in a sense, a “near-adhesion free” form of surgery.